Ending transmission of SARS-CoV-2: sterilizing immunity using an intranasal subunit vaccine
A. Leekha, A. Saeedi, S. R. Sefat, M. Kumar, M. M. Paniagua, A. Damian, R. Kulkarni, A. Rezvan, S. Mosoumi, X. Liu, L. J. N. Cooper, M. Sebastian, B. L. Hurst, N. Varadarajan
This paper develops an intranasal multi-antigen vaccine that prevents SARS-CoV-2 infection and transmission by targeting both spike and nucleocapsid proteins.
bioRxiv · Jul 14, 2022Immunology